跳至主要内容
临床试验/NCT04162691
NCT04162691招募中不适用

Single Cell Sequencing Analysis of Thymoma

Zhejiang Cancer Hospital1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2020年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
1
主要终点
Determination of cell population from thymoma

研究概览

简要总结

The purpose of this study is to understand how genetics play a role in thymoma. Intratumoral heterogeneity is among the greatest challenges in precision cancer therapy. However, developments in high-throughput single-cell RNA sequencing (scRNA-seq) may now provide the statistical power to dissect the diverse cellular populations of tumors. This study aims to find out how it affects genetic and protein expression in patients with malignant thymoma, compared to Benign thymoma, at a single-cell level using a flow cytometry and RNA-sequencing protocol.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with thymoma
  • Ability to provide written consent and comply with the protocol
  • At least 18 years of age

排除标准

  • Patients undergoing thymoma treatment
  • Patients with previous malignancy
  • Known HIV positive status.
  • Evidence of abnormality of any immune cell population from a drug-induced or genetic cause.

结局指标

主要结局

Determination of cell population from thymoma

时间窗: through study completion, an average of 1 year

The genes expression and the cell population

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ZHAO An

Principal Investigator

Zhejiang Cancer Hospital

研究点 (1)

Loading locations...

相似试验